Urinary Mycotoxin Testing

Abstract

Urinary mycotoxin testing is unvalidated for evaluation of environmental exposure via inhalation, diagnosis of chronic inflammatory response syndrome (CIRS) or the resolution of any parameter of illness. Urinary mycotoxin test results do not indicate antifungal use in oral, sublingual and intranasal forms. Rampant antifungal use has contributed to fungal and bacterial resistance and multi-nuclear atrophy via beta-tubulin upregulation in vulnerable populations. The Centers for Disease Control (CDC) does not condone urinary mycotoxin testing in conjunction with antifungal use. By contrast, in 2008, the US Government Accountability Office (GAO) supported a strict case definition for exposure to water-damaged buildings. Globally, 60–100% of healthy individuals have mycotoxins in their urine. Urinary mycotoxin presence does not correlate with human health parameters. Urinary mycotoxin testing most strongly indicates ingestion of stored food. There are few cases of human illness associated with mycotoxicosis. Good farming practices reduce these risks further.

Symptom Clusters